Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Recombinant human immunodeficiency virus-1 transactivator of transcription1-86 allosterically modulates dopamine transporter activity.

× No keyword cloud information.

14 in total

1. Studies of the biogenic amine transporters. 12. Identification of novel partial inhibitors of amphetamine-induced dopamine release.

Authors: Joseph J Pariser; John S Partilla; Christina M Dersch; Subramaniam Ananthan; Richard B Rothman
Journal: J Pharmacol Exp Ther Date: 2008-04-25 Impact factor: 4.030

2. Detection of HIV-1 Tat and JCV capsid protein, VP1, in AIDS brain with progressive multifocal leukoencephalopathy.

Authors: L Del Valle; S Croul; S Morgello; S Amini; J Rappaport; K Khalili
Journal: J Neurovirol Date: 2000-06 Impact factor: 2.643

3. [3H]WIN 35,428 binding to the dopamine uptake carrier. II. Effect of membrane fractionation procedure and freezing.

Authors: M E Reith; L L Coffey
Journal: J Neurosci Methods Date: 1994-01 Impact factor: 2.390

4. Dopamine uptake inhibitors but not dopamine releasers induce greater increases in motor behavior and extracellular dopamine in adolescent rats than in adult male rats.

Authors: Q David Walker; Sarah E Morris; Andrew E Arrant; Jacqueline M Nagel; Sarah Parylak; Guiying Zhou; Joseph M Caster; Cynthia M Kuhn
Journal: J Pharmacol Exp Ther Date: 2010-07-06 Impact factor: 4.030

5. Estrogen attenuates gp120- and tat1-72-induced oxidative stress and prevents loss of dopamine transporter function.

Authors: David R Wallace; Stephanie Dodson; Avindra Nath; Rosemarie M Booze
Journal: Synapse Date: 2006-01 Impact factor: 2.562

6. Pharmacological heterogeneity of the cloned and native human dopamine transporter: disassociation of [3H]WIN 35,428 and [3H]GBR 12,935 binding.

Authors: Z B Pristupa; J M Wilson; B J Hoffman; S J Kish; H B Niznik
Journal: Mol Pharmacol Date: 1994-01 Impact factor: 4.436

7. Decreased brain dopaminergic transporters in HIV-associated dementia patients.

Authors: Gene-Jack Wang; Linda Chang; Nora D Volkow; Frank Telang; Jean Logan; Thomas Ernst; Joanna S Fowler
Journal: Brain Date: 2004-08-19 Impact factor: 13.501

8. Intra-accumbal Tat1-72 alters acute and sensitized responses to cocaine.

Authors: S B Harrod; C F Mactutus; S Fitting; U Hasselrot; R M Booze
Journal: Pharmacol Biochem Behav Date: 2008-10 Impact factor: 3.533

9. Decreased brain dopamine transporters are related to cognitive deficits in HIV patients with or without cocaine abuse.

Authors: Linda Chang; Gene-Jack Wang; Nora D Volkow; Thomas Ernst; Frank Telang; Jean Logan; Joanna S Fowler
Journal: Neuroimage Date: 2008-05-20 Impact factor: 6.556

10. Identification and characterization of a novel allosteric modulator (SoRI-6238) of the serotonin transporter.

Authors: Ayon Nandi; Christina M Dersch; Manish Kulshrestha; Subramaniam Ananthan; Richard B Rothman
Journal: Synapse Date: 2004-09-01 Impact factor: 2.562

34 in total

1. Adolescent HIV-1 transgenic rats: evidence for dopaminergic alterations in behavior and neurochemistry revealed by methamphetamine challenge.

Authors: Landhing M Moran; Michael Y Aksenov; Rosemarie M Booze; Katy M Webb; Charles F Mactutus
Journal: Curr HIV Res Date: 2012-07 Impact factor: 1.581

2. Male HIV-1 transgenic rats show reduced cocaine-maintained lever-pressing compared to F344 wildtype rats despite similar baseline locomotion.

Authors: Y Wendy Huynh; Brady M Thompson; Christopher E Larsen; Shilpa Buch; Ming-Lei Guo; Rick A Bevins; Jennifer E Murray
Journal: J Exp Anal Behav Date: 2020-02-20 Impact factor: 2.468

3. Modeling deficits in attention, inhibition, and flexibility in HAND.

Authors: Landhing M Moran; Rosemarie M Booze; Charles F Mactutus
Journal: J Neuroimmune Pharmacol Date: 2014-04-25 Impact factor: 4.147

Review 4. Dopaminergic impact of cART and anti-depressants on HIV neuropathogenesis in older adults.

Authors: Stephanie M Matt; Peter J Gaskill
Journal: Brain Res Date: 2019-08-21 Impact factor: 3.252

5. Selective Vulnerability of Striatal D2 versus D1 Dopamine Receptor-Expressing Medium Spiny Neurons in HIV-1 Tat Transgenic Male Mice.

Authors: Christina J Schier; William D Marks; Jason J Paris; Aaron J Barbour; Virginia D McLane; William F Maragos; A Rory McQuiston; Pamela E Knapp; Kurt F Hauser
Journal: J Neurosci Date: 2017-05-04 Impact factor: 6.167

6. D1/NMDA receptors and concurrent methamphetamine+ HIV-1 Tat neurotoxicity.

Authors: Michael Y Aksenov; M V Aksenova; C F Mactutus; Rosemarie M Booze
Journal: J Neuroimmune Pharmacol Date: 2012-05-03 Impact factor: 4.147

7. [³H]Dopamine Uptake through the Dopamine and Norepinephrine Transporters is Decreased in the Prefrontal Cortex of Transgenic Mice Expressing HIV-1 Transactivator of Transcription Protein.

Authors: Matthew Strauss; Bernadette O'Donovan; Yizhi Ma; Ziyu Xiao; Steven Lin; Michael T Bardo; Pavel I Ortinski; Jay P McLaughlin; Jun Zhu
Journal: J Pharmacol Exp Ther Date: 2020-05-27 Impact factor: 4.030

8. Neurobehavioral alterations in HIV-1 transgenic rats: evidence for dopaminergic dysfunction.

Authors: L M Moran; R M Booze; K M Webb; C F Mactutus
Journal: Exp Neurol Date: 2012-10-11 Impact factor: 5.330

9. Dose-dependent neurocognitive deficits following postnatal day 10 HIV-1 viral protein exposure: Relationship to hippocampal anatomy parameters.

Authors: Sylvia Fitting; Kristen A McLaurin; Rosemarie M Booze; Charles F Mactutus
Journal: Int J Dev Neurosci Date: 2017-10-27 Impact factor: 2.457

Review 10. Interactions of HIV and drugs of abuse: the importance of glia, neural progenitors, and host genetic factors.

Authors: Kurt F Hauser; Pamela E Knapp
Journal: Int Rev Neurobiol Date: 2014 Impact factor: 3.230